Back to search

National and Kapodistrian University of Athens

Κλινική σημασία της έκφρασης των ενζύμων αποακετυλίωσης ιστονών σε νεοπλάσματα σιελογόνων αδένων

Abstract

dc:description

Aim: Salivary gland tumors (SGTs) are of great clinical and research interest, due to their rarity, heterogeneity, potentially aggressive behavior, overlapping histopathological features and their complexed genetic and epigenetic profile. The aim of the study is a) to analyze for the first time and evaluate through immunohistochemistry (IHC) the expression of type-I and type-II histone deacetylating enzymes HDAC (-1, -2, -4, -6) in a significant representative sample of different subtypes of SGTs (benign and malignant), b) to conduct a comparative research between the induced and suppressed expression of HDACs in SGTs c) to statistically investigate significant correlations regarding HDACs expression and patient characteristics (age, sex), and d) to investigate the correlation between the differential expression of HDACs in malignant SGTs with clinicopathological features, and their utility as biomarkers, e) the possible correlations between HDAC overexpression and tumor differentiation characteristics. Also, by conducting a systematic analysis, the aim of this research is to investigate a) for the first time, through bioinformatics transcriptional data, the identification of important interacting and differentially expressed genes (DEGs) in adenoid cystic carcinoma (ACC), b) to validate the bioinformatics analysis results and further evaluate the protein expression levels of DEGs and histone repressive marks, c) review of the literature aiming tο locate related scientific findings regarding the differentially expressed enzymes that regulate histone modifications in SGTs. Methods: During the initial steps of the study, medical records, and archival histopathological material of a total of 58 SGT samples from an equal number of patients were utilized, including 36 cases of benign and 22 cases of malignant SGTs. This was followed by independent re-evaluation of representative sections of each case with hematoxylin-eosin staining by 2 different investigators to confirm the original histological diagnosis, according to the latest classification of head and neck tumors of the World Health Organization (2017). For HDAC-1 and HDAC-2 immunohistochemical staining, were used rabbit-derived polyclonal antibodies, and for HDAC-4 and HDAC-6, mice-derived monoclonal antibodies were used according to the manufacturer's instructions. Positive and negative controls were also performed. The staining was then evaluated, and the H-score was calculated for each case (H-score=score of staining extent + score of stain intensity), statistical analysis was performed (SPSS V25.0.0) and survival curves were constructed using the Kaplan-Meier method. The level of statistical significance for all statistical tests was set at p<0.05.In the second stage of the analysis, we extracted publicly available RNA-Seq data (Bioproject PRJNA287156) from 98 FFPE: 94 AKK and 4 normal salivary gland (SG) tissues. Sequencing of reads was performed on Ion Proton and Ion S5/XL sequencing systems (Thermo Fisher Scientific, USA). Read quality of raw single-end FASTQ files was assessed using FastQC (version 0.11.7). Fit trimming, quality and polyX was performed using fastp (version 0.20.0). Reads were mapped to a decoy-aware transcriptome (gencode41/GRh38) and gene expression quantification was performed using Salmon (version 1.1.0). Mapped reads <2 million were discarded from the sample. The detection of DEGs was performed with the DESeq2 algorithm, using the following statistical significance thresholds: a) False Discovery Rate (FDR)-adjusted p-value <0.05, b)|log2Fold-Change (FC)|>1or<-1 , c) mean value of DESeq2's normalized counts >2 million. 3rd generation enrichment analyses were applied to detect gene ontologies and KEGG (Kyoto Encyclopedia of Genes and Genomes) pathways that were overrepresented among induced and repressed genes using the of WebGestalt gene set analysis. The network analysis of DEGs was performed using Cytoscape (version 3.9.1) and the StringApp Plugin (version 2.0.1), a Cytoscape plugin that allows the import of STRING PPI networks. By querying: “histone modification” in stringApp, the network of interacting and associated histone modification DEGs was obtained. Then, a validation of the bioinformatic analysis was performed through IHC, using medical records and archival histopathological material (FFPE), from a total of 10 SGT patients: 2 benign (pleiomorphic adenomas, PA) and 8 malignant tumors (5 ACC, and 3 polymorphous adenocarcinomas, PAC). The IHC investigation was conducted utilizing the following proteins: Ki-67, p53, SUV39h1, Ezh2, HDAC8, H3K27me3 and H3K9me3. The results were evaluated by two independent researchers in terms of positivity, percentage, and intensity of staining, and finally the relevant literature was reviewed. Results: Induced expression of HDACs was detected in 25%-89% of HDAC positive SGTs. The protein expression of: a) HDAC-1 was expressed nuclearly in 31% of benign, and 14% of malignant OSA. b) HDAC-2 was detected (mainly nuclear) in 86% of benign and 82% of malignant cases. c) HDAC-4 was expressed in 44% of benign and 36% of malignant tumors, predominantly with a nuclear pattern. d) HDAC-6 was expressed in 11% of benign and 18% of malignant OSA, mainly cytoplasmically. In order to reduce sample heterogeneity, benign tumors were grouped with low-grade tumors and compared with high-grade tumors, and the comparison revealed statistically significant groups. HDAC-2 expression is a predictor of positive outcome and was associated with prolonged overall survival in malignant+high-grade SGTs. Overexpression of HDAC-6 was associated with a negative impact on overall survival in malignant+high-grade SGTs, whereas non-expression of HDAC-6 was associated with prolonged long survival. An HDAC-6 inhibitor is proposed as a candidate for improving patients’ survival. The expression of HDACs did not correlate with patients age and/or gender. A network of important protein-protein interaction (PPI) related to histone modifications was revealed for the first time through bioinformatic analysis in ACC. A significant upregulation of TP53 and the histone-modifying enzymes SUV39H1, EZH2, PRMT1, HDAC8, and KDM5B, along with the upregulation of DNA methyltransferase DNMT3A and ubiquitin ligase UHRF1 mRNA levels was detected in ACC tissues with downregulation of lysine acetyltransferase KAT2B levels. The analysis was further validated through protein expression of P53, SUV39H1, EZH2, HDAC8 along with the corresponding histone repressive marks: H3K9me3, H3K27me3. p53 expression was low in PA cases, while induced in PAK and AKK, confirming the relevant literature. EZH2 staining was weak in PA and PAK, and data we detected where in agreement with literature for induced EZH2 expression in AKK, while H3K27me3 expression was observed in all SGTs. The study is the first to detect induced mRNA levels as well as protein expression of SUV39H1 in ACC, compared to PA and PAC tissues. Whereas the induction of H3K9me3 in malignant PAC and ACC, compared to benign PA, indicates a possible functional role of SUV39H1, mediated by the induction of H3K9me3. Also, for the first time in the corresponding literature we detected a significantly induced expression (transcriptional and protein) of HDAC8 in malignant SGTs (ACC, PAC) compared to benign SGTs (PA), highlighting the scientific hypothesis for further researchers. Conclusions: Histone deacetylases and histone modifications play an important role in SGTs. Regarding histone deacetylases, in our study the expression of HDAC-2 emerges as an important positive prognostic factor for SGTs (good prognosis), while the expression of HDAC-6 as negative (poor prognosis). As overexpression of HDAC-6 was associated with poor prognosis, inhibition of HDAC-6 could contribute to improving the survival of these patients. Even though our study supports statistically significant results of clinical importance, the main criticism of such studies remains the small number of patients with rare neoplasms included in the study, and the heterogeneity of the histological groups within the studies. Further analysis, in larger cohorts on distinct histological subtypes of SGTs, is necessary for unraveling the prognostic role of HDACs in SGTs, and also to unlock their potential as therapeutic targets, using HDAC inhibitors for the management of SGTs patients. Overall, our study revealed a network of interacting histone modifying factors involved in SGT gene regulation, highlighting the critical role of epigenetic mechanisms in salivary gland tumorigenesis. Among the differentially expressed genes identified in ACCs, the key methyltransferases SUV39H1 and EZH2, as well as deacetylase HDAC8 were further detected overexpressed in tissue samples, confirming the DEG network as well as some previous studies. Moreover, the increased expression of histone repressive marks H3K9me3 and H3K27me3 in SGTs, suggests a possible functional role of SUV39H1 and EZH2, respectively, with a negative impact on gene regulation. Further studies are needed to confirm the possible physical interactions between the detected histone modifying factors as well as to elucidate the molecular mechanisms and functional role of the identified DEGs in SGTs.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2024

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Manou, Maria
  • Μάνου, Μαρία

Subjects

dc:subject × 12

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/56196

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Manou, Maria; Μάνου, Μαρία. Κλινική σημασία της έκφρασης των ενζύμων αποακετυλίωσης ιστονών σε νεοπλάσματα σιελογόνων αδένων. National and Kapodistrian University of Athens, 2024. http://hdl.handle.net/10442/hedi/56196